Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Don't expect the half of $7M in PDS licenses mentioned to hit PTSC's bottom line

True to a point. If the money stays with PDS, it is there to cover expenses and fund the fight. With the history TPL has on allegedly over charging and conflating expenses, it will be interesting to see how much of that $7M that was there on Jan 13, is there on Feb 28. So while it was there in Cash and Equivalents on that date per the note in the 10q, it doesn't mean it will reflect as profit for PDS by the time the quarter closed.

Let's hope you're right and that the expenses since 1/13 haven't wiped most of that out, or better yet, that there have been additional license revenue that will have pumped it up higher, and allowed for distribution to PTSC (so as to secure that money for our side to squander! lol).

Share
New Message
Please login to post a reply